{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:34:21Z","timestamp":1794566061013,"version":"4.9.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":801,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41379-020-0588-y","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T11:04:45Z","timestamp":1591355085000},"page":"2269-2279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Molecular characterization of diffuse malignant peritoneal mesothelioma"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-1591","authenticated-orcid":false,"given":"Yin P.","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-6938","authenticated-orcid":false,"given":"Lucian R.","family":"Chirieac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0588-y_bib1","unstructured":"Galateau-Salle F, Churg A, Roggli V, Chirieac LR, Attanoos R, Borczuk A, et al. Tumours of the pleura. Mesothelial tumours. In: Travis WD, Brambilla E, Burke A, Marx A, Nicholson AG, editors. World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus, and heart, Vol., 4th edn. IARC Press: Lyon, France, 2015. p156."},{"key":"10.1038\/s41379-020-0588-y_bib2","first-page":"935","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1038\/s41379-020-0588-y_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6608a3","article-title":"Malignant Mesothelioma Mortality\u2014United States, 1999\u20132015","volume":"66","author":"Mazurek","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1038\/s41379-020-0588-y_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/95.4.493","article-title":"Malignant peritoneal mesothelioma in childhood with long-term survival","volume":"95","author":"Geary","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cncr.10209","article-title":"Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients","volume":"94","author":"Kerrigan","year":"2002","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0588-y_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2559.2008.03029.x","article-title":"Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases","volume":"52","author":"Moran","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-0588-y_bib7","doi-asserted-by":"crossref","first-page":"16766","DOI":"10.18632\/oncotarget.4414","article-title":"Distinctive clinical characteristics of malignant mesothelioma in young patients","volume":"6","author":"Thomas","year":"2015","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0588-y_bib8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/01.pas.0000165529.78945.dc","article-title":"Localized malignant mesothelioma","volume":"29","author":"Allen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib10","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1158\/1078-0432.CCR-04-1884","article-title":"P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma","volume":"11","author":"Borczuk","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0588-y_bib11","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2016.04.015","article-title":"Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array","volume":"55","author":"Chirac","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-020-0588-y_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant mesothelioma and its non-asbestos causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-020-0588-y_bib15","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/1097-0142(19850501)55:9<1968::AID-CNCR2820550923>3.0.CO;2-9","article-title":"Malignant mesothelioma secondary to chronic inflammation and old scars. Two new cases and review of the literature","volume":"55","author":"Hillerdal","year":"1985","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0588-y_bib16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/jclinpath-2018-205099","article-title":"Malignant peritoneal mesothelioma in patients with endometriosis","volume":"71","author":"Butnor","year":"2018","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.1983.1.11.695","article-title":"Malignant mesothelioma following radiation exposure","volume":"1","author":"Antman","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2068","article-title":"A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes","volume":"7","author":"Carbone","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-020-0588-y_bib19","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1097\/MPH.0000000000000262","article-title":"Malignant peritoneal mesothelioma in an adolescent male with BAP1 deletion","volume":"37","author":"Taylor","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib20","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-020-0588-y_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Lo Iacono","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-0588-y_bib24","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-16-0229","article-title":"Genomic landscape of malignant mesotheliomas","volume":"15","author":"Kato","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/s41379-020-0588-y_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1038\/s41379-020-0588-y_bib26","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-020-0588-y_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09307-6","article-title":"Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications","volume":"10","author":"Blum","year":"2019","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-020-0588-y_bib28","doi-asserted-by":"crossref","unstructured":"Quetel L, Meiller C, Assie JB, Blum Y, Imbeaud S, Montagne F, et al. Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival. Mol Oncol. 2020. https:\/\/doi.org\/10.1002\/878-0261.12651.","DOI":"10.1002\/1878-0261.12651"},{"key":"10.1038\/s41379-020-0588-y_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-015-0485-1","article-title":"BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma","volume":"13","author":"Alakus","year":"2015","journal-title":"J Transl Med"},{"key":"10.1038\/s41379-020-0588-y_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1010-x","article-title":"Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome","volume":"15","author":"Chao","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1038\/s41379-020-0588-y_bib31","doi-asserted-by":"crossref","first-page":"e0119689","DOI":"10.1371\/journal.pone.0119689","article-title":"Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing","volume":"10","author":"Sheffield","year":"2015","journal-title":"PLoS One"},{"key":"10.1038\/s41379-020-0588-y_bib32","doi-asserted-by":"crossref","first-page":"E739","DOI":"10.3390\/ijms17050739","article-title":"A tumor-specific neo-antigen caused by a frameshift mutation in BAP1 is a potential personalized biomarker in malignant peritoneal mesothelioma","volume":"17","author":"Lai","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41379-020-0588-y_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00408-015-9814-7","article-title":"Driver gene and novel mutations in asbestos-exposed lung adenocarcinoma and malignant mesothelioma detected by exome sequencing","volume":"194","author":"Maki-Nevala","year":"2016","journal-title":"Lung"},{"key":"10.1038\/s41379-020-0588-y_bib34","first-page":"2331","article-title":"Genome-based mutational analysis by next generation sequencing in patients with malignant pleural and peritoneal mesothelioma","volume":"36","author":"Ugurluer","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1038\/s41379-020-0588-y_bib35","doi-asserted-by":"crossref","first-page":"e5447","DOI":"10.1097\/MD.0000000000005447","article-title":"Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report","volume":"95","author":"Vanni","year":"2016","journal-title":"Med (Baltim)"},{"key":"10.1038\/s41379-020-0588-y_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/PAS.0000000000000864","article-title":"A subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1\/FUS-ATF1 fusions","volume":"41","author":"Desmeules","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/modpathol.2016.188","article-title":"Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X","volume":"30","author":"Joseph","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib38","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1634\/theoncologist.2016-0488","article-title":"ALK fusions in a wide variety of tumor types respond to Anti-ALK targeted therapy","volume":"22","author":"Ross","year":"2017","journal-title":"Oncologist"},{"key":"10.1038\/s41379-020-0588-y_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.6004\/jnccn.2018.7012","article-title":"Integrated histogenetic analysis reveals BAP1-mutated epithelioid mesothelioma in a patient with cancer of unknown primary","volume":"16","author":"Bochtler","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/s41379-020-0588-y_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK rearrangements in malignant peritoneal mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-018-0651-4","article-title":"First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications","volume":"19","author":"Loffler","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1038\/s41379-020-0588-y_bib42","doi-asserted-by":"crossref","first-page":"E5817","DOI":"10.3390\/ijms20225817","article-title":"Molecular signatures for combined targeted treatments in diffuse malignant peritoneal mesothelioma","volume":"20","author":"Belfiore","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41379-020-0588-y_bib43","doi-asserted-by":"crossref","first-page":"a003566","DOI":"10.1101\/mcs.a003566","article-title":"Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response","volume":"5","author":"Lund-Andersen","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1038\/s41379-020-0588-y_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00048","article-title":"STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment","volume":"3","author":"Ruschoff","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0620-3","article-title":"BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma","volume":"11","author":"Shrestha","year":"2019","journal-title":"Genome Med"},{"key":"10.1038\/s41379-020-0588-y_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.humpath.2018.07.033","article-title":"Primary peritoneal epithelioid mesothelioma of clear cell type with a novel VHL gene mutation: a case report","volume":"83","author":"Smith-Hannah","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/PAS.0000000000001359","article-title":"Molecular analysis of a patient with neurofibromatosis 2 (NF2) and peritoneal malignant mesothelioma","volume":"44","author":"Glass","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib48","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-0588-y_bib49","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-0588-y_bib50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib51","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib52","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jtho.2016.12.019","article-title":"BAP1 is altered by copy number loss, mutation, and\/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas","volume":"12","author":"Leblay","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/gcc.22068","article-title":"RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12)","volume":"52","author":"Panagopoulos","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/s41379-020-0588-y_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/his.12779","article-title":"Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum","volume":"68","author":"Loharamtaweethong","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-0588-y_bib57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jtho.2019.11.011","article-title":"Anaplastic lymphoma kinase gene rearrangement in children and young adults with mesothelioma","volume":"15","author":"Mian","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000478-198206000-00003","article-title":"Malignant mesothelioma: ultrastructural distinction from adenocarcinoma","volume":"6","author":"Warhol","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/0008-5472.CAN-15-0751","article-title":"Gender-specific molecular and clinical features underlie malignant pleural mesothelioma","volume":"76","author":"De Rienzo","year":"2016","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-020-0588-y_bib60","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"10.1038\/s41379-020-0588-y_bib61","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","article-title":"SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma","volume":"31","author":"Kolin","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib62","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41379-019-0371-0","article-title":"Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma","volume":"33","author":"Brich","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib64","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/modpathol.2009.186","article-title":"CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival","volume":"23","author":"Krasinskas","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/15384047.2016.1145850","article-title":"Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration","volume":"17","author":"Borczuk","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/s41379-020-0588-y_bib67","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/PAS.0000000000000495","article-title":"Sarcomatoid peritoneal mesothelioma: clinicopathologic correlation of 13 cases","volume":"39","author":"Pavlisko","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib68","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2018.79.0352","article-title":"A subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations","volume":"36","author":"Pastorino","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib69","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1097\/MPH.0000000000001294","article-title":"Malignant peritoneal mesothelioma in an infant with familial ATM mutations","volume":"40","author":"Mijalovsky","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1038\/s41379-020-0588-y_bib70","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-0588-y_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-11-0962","article-title":"Polycomb repressor complex-2 is a novel target for mesothelioma therapy","volume":"18","author":"Kemp","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0588-y_bib72","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/his.13123","article-title":"Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma","volume":"70","author":"Shinozaki-Ushiku","year":"2017","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-0588-y_bib73","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat Med"},{"key":"10.1038\/s41379-020-0588-y_bib74","doi-asserted-by":"crossref","first-page":"a026575","DOI":"10.1101\/cshperspect.a026575","article-title":"Role of the polycomb repressive complex 2 (PRC2) in transcriptional regulation and cancer","volume":"6","author":"Laugesen","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1038\/s41379-020-0588-y_bib75","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2017.153","article-title":"Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation","volume":"31","author":"Goode","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib76","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.13726","article-title":"Adenomatoid tumour of the uterus is frequently associated with iatrogenic immunosuppression","volume":"73","author":"Tamura","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-0588-y_bib77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41379-019-0330-9","article-title":"Molecular characterization of localized pleural mesothelioma","volume":"33","author":"Hung","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0588-y_bib79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cancergencyto.2010.07.120","article-title":"Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor","volume":"202","author":"Sukov","year":"2010","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0588-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0588-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0588-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:36:44Z","timestamp":1760229404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222004483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0893395222004483"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0588-y","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization of diffuse malignant peritoneal mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0588-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}